
National Research Corporation NRC
$ 21.85
0.27%
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
22.4 M |
Market Cap[1] |
$ 489 M |
EBITDA (LTM) |
$ 19.9 M |
P/E (LTM) |
122.44 |
P/S (LTM) |
3.16 |
EPS (LTM) |
0.16 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Biomerica
BMRA
|
$ 2.14 | 1.9 % | $ 4.92 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.17 | 0.88 % | $ 6.37 M | Nasdaq Capital Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 1.21 | 0.79 % | $ 1.61 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 14.3 | 0.7 % | $ 486 M | Nasdaq Global Select Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 242.76 | 0.02 % | $ 26.9 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 88.44 | 3.05 % | $ 4.14 B | Nasdaq Global Select Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 291.5 | 0.16 % | $ 14.4 B | NYSE,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 6.77 | 1.18 % | $ 27 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 90.82 | 1.71 % | $ 35.4 B | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 398.58 | 0.64 % | $ 28.8 B | NYSE,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 3.16 | 1.92 % | $ 293 M | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
ENDRA Life Sciences
NDRA
|
$ 5.01 | 4.53 % | $ 3.94 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 18.05 | 7.31 % | $ 2.31 B | Nasdaq Global Select Market,SPB | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.48 | 1.11 % | $ 113 K | Nasdaq Capital Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.4 | 0.32 % | $ 420 M | Nasdaq Global Select Market,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 170.02 | 0.18 % | $ 13.3 B | Nasdaq Global Select Market,SPB | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.45 | 2.11 % | $ 6.41 M | Nasdaq Global Select Market | ||
|
IQVIA Holdings
IQV
|
$ 261.75 | 0.05 % | $ 45 B | NYSE,SPB | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.